13D/13G Filings - Design Therapeutics Inc. (DSGN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-09
4:25 pm
Purchase
2021-12-31 13G Design Therapeutics, Inc.
DSGN
Star Irrevocable Trust #1 dated April 22, 2019 3,834,355
6.900%
3,834,355increase
(New Position)
Filing
History
2021-04-09
4:07 pm
Purchase
2021-03-30 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,114,844
9.200%
5,114,844increase
(New Position)
Filing
History
2021-04-09
3:38 pm
Purchase
2021-03-30 13D Design Therapeutics, Inc.
DSGN
SR One Capital Fund I Aggregator LP 5,641,476
10.500%
5,641,476increase
(New Position)
Filing
History
Goto Prev, 0, 1